Search companies or stocks...
IMVTImmunovant, Inc.
At close · 01 Sept 2026, 08:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully…
Current stock price of Immunovant, Inc. (IMVT) stock is $39.900. The stock price is -2.25% lower in the session. The intraday range can be seen from this page. Volume of Immunovant, Inc. (IMVT) stock is 1.58M.
Last updated at 01 Sept 2026, 08:00 pm.
The stock price of Immunovant, Inc. (IMVT) can change with earnings, company news, and overall market sentiment. Immunovant, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Immunovant, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for IMVT on this page is -14.15. EPS on this page is -2.82. Compare those figures with peers and growth expectations before deciding if the current Immunovant, Inc. price is justified.
Historical performance for Immunovant, Inc. (IMVT) is shown on the price chart on this page. Review multi-period moves alongside volume to see how IMVT reacted to past earnings and market events.
Buying Immunovant, Inc. (IMVT) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
